University of Chicago: Carcinoma trials

The registry lists 20 Carcinoma studies with University of Chicago as lead sponsor. 1 are open to participants now and 11 have results posted.

Phase 1 4Phase 2 12Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Personalized, Adaptive Treatment for Locally Advanced Head and Neck CancerRecruitingNCT06005324Phase 1
• De-Escalation Therapy for Human Papillomavirus Negative DiseaseCompletedNCT03944915Phase 2Results posted
• BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck CancerTerminatedNCT02706691Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney CancerTerminatedNCT02542202Not applicableResults posted
• Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerCompletedNCT02258659Phase 2Results posted
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
• Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck LesionsCompletedNCT01414426Phase 2Results posted
• Study in Locally Advanced Squamous Cell Carcinoma of Head and NeckTerminatedNCT01133678Phase 2Results posted
• Cetuximab and Lenalidomide in Head and NeckCompletedNCT01133665Phase 2Results posted
• A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in SituTerminatedNCT01060345Phase 2Results posted
• A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell CarcinomaTerminatedNCT00523640Phase 2Results posted
• Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckCompletedNCT00519077Phase 2Results posted
• Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT03325465Phase 2
• Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver CancerTerminatedNCT03203304Phase 1
• Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal CancerTerminatedNCT01949740
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
• Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast CancerWithdrawnNCT01791998Not applicable
• Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
• MRI Study of BAY 43-9006 in Metastatic Renal Cell CarcinomaCompletedNCT00606866Phase 3
• Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell CarcinomaTerminatedNCT00203866Phase 2